Masanday, Kairi .
HRN: 25-57-37 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/05/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/05/2025
03/11/2025
IV
95
Q24
PCAP
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes